Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit.

Collett D, Mumford L, Banner NR, Neuberger J, Watson C.

Am J Transplant. 2010 Aug;10(8):1889-96. doi: 10.1111/j.1600-6143.2010.03181.x.

2.

Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.

Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V.

Clin Transplant. 1996 Jun;10(3):248-55.

PMID:
8826661
3.

Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease.

Otley CC, Cherikh WS, Salasche SJ, McBride MA, Christenson LJ, Kauffman HM.

J Am Acad Dermatol. 2005 Nov;53(5):783-90. Epub 2005 Sep 22.

PMID:
16243126
4.

De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.

Baccarani U, Adani GL, Montanaro D, Risaliti A, Lorenzin D, Avellini C, Tulissi P, Groppuzzo M, Currò G, Luvisetto F, Beltrami A, Bresadola V, Viale PL, Bresadola F.

Transplant Proc. 2006 May;38(4):1135-7.

PMID:
16757287
5.

Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study.

Naldi L, Fortina AB, Lovati S, Barba A, Gotti E, Tessari G, Schena D, Diociaiuti A, Nanni G, La Parola IL, Masini C, Piaserico S, Peserico A, Cainelli T, Remuzzi G.

Transplantation. 2000 Nov 27;70(10):1479-84.

PMID:
11118094
6.

A population-based study of skin cancer incidence and prevalence in renal transplant recipients.

Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM.

Br J Dermatol. 2006 Mar;154(3):498-504.

PMID:
16445782
7.

Risk of malignant neoplasms after liver transplantation: a population-based study.

Aberg F, Pukkala E, Höckerstedt K, Sankila R, Isoniemi H.

Liver Transpl. 2008 Oct;14(10):1428-36. doi: 10.1002/lt.21475.

8.

Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.

Ju MK, Joo DJ, Kim SJ, Huh KH, Kim MS, Jeon KO, Kim HJ, Kim SI, Kim YS.

Transpl Int. 2009 Jun;22(6):644-53. doi: 10.1111/j.1432-2277.2009.00846.x. Epub 2009 Feb 10.

9.

Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.

Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, Shah T.

Transplantation. 2012 Nov 27;94(10):990-8. doi: 10.1097/TP.0b013e318270bc7b.

PMID:
23085553
10.

Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.

Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, Rutgrink E, Ramsoebhag A, Hop A, Persijn G, Laufer G.

Clin Transpl. 2003:89-100.

PMID:
15387100
11.

A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening.

Johnson EE, Leverson GE, Pirsch JD, Heise CP.

J Gastrointest Surg. 2007 Mar;11(3):272-9.

PMID:
17458597
12.
13.

Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.

Jensen AO, Svaerke C, Farkas D, Pedersen L, Kragballe K, Sørensen HT.

Acta Derm Venereol. 2010 Sep;90(5):474-9. doi: 10.2340/00015555-0919.

14.

Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales.

Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM.

Transplantation. 2005 Sep 27;80(6):759-64.

PMID:
16210962
15.

Cancer incidence among Canadian kidney transplant recipients.

Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y.

Am J Transplant. 2007 Apr;7(4):941-8. Epub 2007 Feb 28.

16.

Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.

Tessari G, Naldi L, Boschiero L, Nacchia F, Fior F, Forni A, Rugiu C, Faggian G, Sassi F, Gotti E, Fiocchi R, Talamini G, Girolomoni G.

Arch Dermatol. 2010 Mar;146(3):294-9. doi: 10.1001/archdermatol.2009.377.

PMID:
20231501
17.

Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.

Kellerman L, Neugut A, Burke B, Mancini D.

Am J Cardiol. 2009 Feb 15;103(4):562-6. doi: 10.1016/j.amjcard.2008.10.026. Epub 2008 Dec 26.

PMID:
19195521
18.
19.

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.

Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, Rakela J, Irish W, Fung JJ.

Transplantation. 1998 Nov 15;66(9):1193-200.

PMID:
9825817
20.

Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.

Tjon AS, Sint Nicolaas J, Kwekkeboom J, de Man RA, Kazemier G, Tilanus HW, Hansen BE, van der Laan LJ, Tha-In T, Metselaar HJ.

Liver Transpl. 2010 Jul;16(7):837-46. doi: 10.1002/lt.22064.

Supplemental Content

Support Center